{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:56:52Z","timestamp":1790881012583,"version":"4.1.0"},"reference-count":132,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cardiometabolic diseases (CMD) are leading causes of death and disability worldwide, with complex pathophysiological mechanisms in which inflammation plays a crucial role. This review aims to elucidate the molecular and cellular mechanisms within the inflammatory microenvironment of atherosclerosis, hypertension and diabetic cardiomyopathy. In atherosclerosis, oxidized low-density lipoprotein (ox-LDL) and pro-inflammatory cytokines such as Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-\u03b1) activate immune cells contributing to foam cell formation and arterial wall thickening. Hypertension involves the activation of the renin-angiotensin system (RAS) alongside oxidative stress-induced endothelial dysfunction and local inflammation mediated by T cells. In diabetic cardiomyopathy, a high-glucose environment leads to the accumulation of advanced glycation end products (AGEs), activating the Receptor for Advanced Glycation Endproducts (RAGE) and triggering inflammatory responses that further damage cardiac and microvascular function. In summary, the inflammatory mechanisms in different types of metabolic cardiovascular diseases are complex and diverse; understanding these mechanisms deeply will aid in developing more effective individualized treatment strategies.<\/jats:p>","DOI":"10.3389\/fcvm.2024.1529903","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T01:11:24Z","timestamp":1736817084000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Mechanisms of inflammatory microenvironment formation in cardiometabolic diseases: molecular and cellular perspectives"],"prefix":"10.3389","volume":"11","author":[{"given":"Menghua","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e3502","DOI":"10.1002\/dmrr.3502","article-title":"Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors","volume":"38","author":"Silveira Rossi","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1258\/000456307780480963","article-title":"Metabolic syndrome and cardiovascular disease","volume":"44","author":"Qiao","year":"2007","journal-title":"Ann Clin Biochem"},{"key":"B3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1080\/07853890500401234","article-title":"The metabolic syndrome and cardiovascular disease","volume":"38","author":"Bonora","year":"2006","journal-title":"Ann Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.mpmed.2014.11.006","article-title":"Metabolic syndrome","volume":"43","author":"Han","year":"2015","journal-title":"Medicine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The metabolic syndrome","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocr Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis Model Mech"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1007\/s00125-023-05992-7","article-title":"Lipotoxicity-polarised macrophage-derived exosomes regulate mitochondrial fitness through Miro1-mediated mitophagy inhibition and contribute to type 2 diabetes development in mice","volume":"66","author":"Li","year":"2023","journal-title":"Diabetologia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/obr.12229","article-title":"Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies","volume":"16","author":"O'Neill","year":"2015","journal-title":"Obes Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1161\/01.CIR.97.6.596","article-title":"Emerging epidemic of cardiovascular disease in developing countries","volume":"97","author":"Reddy","year":"1998","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1048515","DOI":"10.3389\/fepid.2023.1048515","article-title":"The burden of cardiovascular diseases attributable to metabolic risk factors and its change from 1990 to 2019: a systematic analysis and prediction","volume":"3","author":"Wang","year":"2023","journal-title":"Front Epidemiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1024722","DOI":"10.3389\/fnut.2022.1024722","article-title":"Effects of essential oil extracted from Artemisia argyi leaf on lipid metabolism and gut microbiota in high-fat diet-fed mice","volume":"9","author":"Wang","year":"2022","journal-title":"Front Nutr"},{"key":"B12","doi-asserted-by":"crossref","first-page":"e180008","DOI":"10.1590\/1980-549720180008.supl.2","article-title":"Cardiometabolic diseases","volume":"21","author":"Ferreira","year":"2019","journal-title":"Rev Bras Epidemiol"},{"key":"B13","doi-asserted-by":"crossref","first-page":"555834","DOI":"10.19080\/JOCCT.2018.12.555834","article-title":"Cardiometabolic diseases: a global perspective","volume":"12","author":"Rao","year":"2018","journal-title":"J Cardiol Cardiovasc Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.2174\/1381612825666190925163827","article-title":"A brief review of cardiovascular diseases, associated risk factors and current treatment regimes","volume":"25","author":"Flora","year":"2019","journal-title":"Curr Pharm Des"},{"key":"B15","doi-asserted-by":"crossref","first-page":"7092151","DOI":"10.1155\/2019\/7092151","article-title":"Vascular inflammation and oxidative stress: major triggers for cardiovascular disease","volume":"2019","author":"Steven","year":"2019","journal-title":"Oxid Med Cell Longevity"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1253\/circj.CJ-11-1184","article-title":"Chronic inflammation links cardiovascular, metabolic and renal diseases","volume":"75","author":"Manabe","year":"2011","journal-title":"Circ J"},{"key":"B17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/B978-0-12-813792-5.00003-3","article-title":"Inflammation and cardiovascular diseases","volume-title":"The Impact of Nutrition and Statins on Cardiovascular Diseases","author":"Tsoupras","year":"2019"},{"key":"B18","doi-asserted-by":"publisher","first-page":"104023","DOI":"10.1016\/j.mvr.2020.104023","article-title":"Cardiovascular diseases and metabolic abnormalities associated with obesity: what is the role of inflammatory responses? A systematic review","volume":"131","author":"Hamjane","year":"2020","journal-title":"Microvasc Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/cvr\/cvx012","article-title":"Inflammation and metabolic cardiomyopathy","volume":"113","author":"Nishida","year":"2017","journal-title":"Cardiovasc Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000356535","article-title":"Chronic low-grade inflammation in metabolic disorders: relevance for behavioral symptoms","volume":"21","author":"Lasselin","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3390\/ijms21051835","article-title":"The diabetes mellitus\u2013atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation","volume":"21","author":"Poznyak","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/j.1742-1241.2008.01789.x","article-title":"Modulating an oxidative-inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function","volume":"62","author":"Lamb","year":"2008","journal-title":"Int J Clin Pract"},{"key":"B23","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3892\/mmr.2015.4606","article-title":"Effects of miR-590 on oxLDL-induced endothelial cell apoptosis: roles of p53 and NF-\u03baB","volume":"13","author":"Bao","year":"2016","journal-title":"Mol Med Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s11655-023-3598-z","article-title":"Polypeptide from Moschus suppresses lipopolysaccharide-induced inflammation by inhibiting NF-\u03ba B-ROS\/NLRP3 pathway","volume":"29","author":"Yi","year":"2023","journal-title":"Chin J Integr Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejphar.2015.04.050","article-title":"The impact of mast cells on cardiovascular diseases","volume":"778","author":"Kritikou","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2050312120965752","DOI":"10.1177\/2050312120965752","article-title":"Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer","volume":"8","author":"Amin","year":"2020","journal-title":"SAGE Open Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2017.05.005","article-title":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases","volume":"100","author":"Incalza","year":"2018","journal-title":"Vasc Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"34121","DOI":"10.1007\/s11356-021-14109-9","article-title":"Management of oxidative stress and inflammation in cardiovascular diseases: mechanisms and challenges","volume":"28","author":"Donia","year":"2021","journal-title":"Environ Sci Pollut Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.2174\/138161209789058093","article-title":"Oxidative stress, endothelial dysfunction and atherosclerosis","volume":"15","author":"Victor","year":"2009","journal-title":"Curr Pharm Des"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1250509","DOI":"10.3389\/fnut.2023.1250509","article-title":"Sodium intake and the risk of various types of cardiovascular diseases: a Mendelian randomization study","volume":"10","author":"Fu","year":"2023","journal-title":"Front Nutr"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.clinbiochem.2009.05.018","article-title":"Hepatic insulin resistance, metabolic syndrome and cardiovascular disease","volume":"42","author":"Meshkani","year":"2009","journal-title":"Clin Biochem"},{"key":"B32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian Randomization","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1295040","DOI":"10.3389\/fendo.2023.1295040","article-title":"Assessing causal associations of hyperparathyroidism with blood counts and biochemical indicators: a Mendelian randomization study","volume":"14","author":"Jiang","year":"2023","journal-title":"Front Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e38610","DOI":"10.1097\/MD.0000000000038610","article-title":"Assessing causal associations of bile acids with obesity indicators: a Mendelian randomization study","volume":"103","author":"Huang","year":"2024","journal-title":"Medicine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1401648","DOI":"10.3389\/fendo.2024.1401648","article-title":"Unveiling the causal link between metabolic factors and ovarian cancer risk using Mendelian randomization analysis","volume":"15","author":"Han","year":"2024","journal-title":"Front Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"111679","DOI":"10.1016\/j.diabres.2024.111679","article-title":"The causal relationship between metabolic syndrome and its components and cardiovascular disease: a Mendelian randomization study","volume":"211","author":"Wu","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/jcsm.13443","article-title":"Metabolic syndrome and cardiovascular disease in cancer survivors","volume":"15","author":"Ueno","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1086731","DOI":"10.3389\/fendo.2023.1086731","article-title":"Sheehan syndrome: cardiovascular and metabolic comorbidities","volume":"14","author":"Laway","year":"2023","journal-title":"Front Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3892\/mmr.2024.13219","article-title":"Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation-mediating treatment options","volume":"29","author":"Varra","year":"2024","journal-title":"Mol Med Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1448535","DOI":"10.3389\/fimmu.2024.1448535","article-title":"Metabolic mechanisms orchestrated by Sirtuin family to modulate inflammatory responses","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"114545","DOI":"10.1016\/j.biopha.2023.114545","article-title":"Metaflammation in glucolipid metabolic disorders: pathogenesis and treatment","volume":"161","author":"Xiong","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.2174\/138161212802481237","article-title":"Atherosclerosis as an inflammatory disease","volume":"18","author":"Tuttolomondo","year":"2012","journal-title":"Curr Pharm Des"},{"key":"B43","doi-asserted-by":"publisher","first-page":"34161","DOI":"10.1038\/srep34161","article-title":"Impact of high fat diet on long non-coding RNAs and messenger RNAs expression in the aortas of ApoE(\u2212\/\u2212) mice","volume":"6","author":"Bao","year":"2016","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications","volume":"116","author":"Tabas","year":"2007","journal-title":"Circulation"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1321576","DOI":"10.3389\/fendo.2023.1321576","article-title":"Endocrine and metabolic factors and the risk of idiopathic pulmonary fibrosis: a Mendelian randomization study","volume":"14","author":"Jiang","year":"2023","journal-title":"Front Endocrinol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3390\/medicina58020299","article-title":"Atherosclerosis development and progression: the role of atherogenic small, dense LDL","volume":"58","author":"Vekic","year":"2022","journal-title":"Medicina (B Aires)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"707529","DOI":"10.3389\/fcvm.2021.707529","article-title":"Role of lipid accumulation and inflammation in atherosclerosis: focus on molecular and cellular mechanisms","volume":"8","author":"Malekmohammad","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.vph.2018.05.005","article-title":"Cinnamaldehyde protects VSMCs against ox-LDL-induced proliferation and migration through S arrest and inhibition of p38, JNK\/MAPKs and NF-\u03baB","volume":"108","author":"Li","year":"2018","journal-title":"Vasc Pharmacol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1481505","DOI":"10.3389\/fcell.2024.1481505","article-title":"An update on ox-LDL-inducing vascular smooth muscle cell-derived foam cells in atherosclerosis","volume":"12","author":"Guo","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"857331","DOI":"10.3389\/fphar.2022.857331","article-title":"Effect of extracellular vesicles from multiple cells on vascular smooth muscle cells in atherosclerosis","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.31083\/j.fbl2904161","article-title":"A review: the significance of toll-like receptors 2 and 4, and NF-\u03baB signaling in endothelial cells during atherosclerosis","volume":"29","author":"Yan","year":"2024","journal-title":"Front Biosci"},{"key":"B52","doi-asserted-by":"crossref","first-page":"e37727","DOI":"10.1016\/j.heliyon.2024.e37727","article-title":"Vascular smooth muscle cell phenotypic switching in atherosclerosis","volume":"10","author":"Yu","year":"2024","journal-title":"Heliyon"},{"key":"B53","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3389\/fphys.2018.00654","article-title":"Lipid and non-lipid factors affecting macrophage dysfunction and inflammation in atherosclerosis","volume":"9","author":"Gibson","year":"2018","journal-title":"Front Physiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1113827","DOI":"10.3389\/fcvm.2023.1113827","article-title":"The role of monocytes in thrombotic diseases: a review","volume":"10","author":"Han","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"818890","DOI":"10.3389\/fcvm.2022.818890","article-title":"The role of interleukin-6 family members in cardiovascular diseases","volume":"9","author":"Feng","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"745061","DOI":"10.3389\/fphar.2021.745061","article-title":"Interleukin-6: a novel target for cardio-cerebrovascular diseases","volume":"12","author":"Su","year":"2021","journal-title":"Front Pharmacol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/cells10020226","article-title":"Inflammatory chemokines in atherosclerosis","volume":"10","author":"Gencer","year":"2021","journal-title":"Cells"},{"key":"B58","doi-asserted-by":"publisher","first-page":"630536","DOI":"10.3389\/fendo.2021.630536","article-title":"Nuclear receptors in the control of the NLRP3 inflammasome pathway","volume":"12","author":"Duez","year":"2021","journal-title":"Front Endocrinol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.it.2011.01.003","article-title":"Inflammasome activation and IL-1\u03b2 and IL-18 processing during infection","volume":"32","author":"Van de Veerdonk","year":"2011","journal-title":"Trends Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.coi.2011.07.005","article-title":"Cross-regulation between the IL-1\u03b2\/IL-18 processing inflammasome and other inflammatory cytokines","volume":"23","author":"Barker","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3389\/fimmu.2019.01592","article-title":"Regulatory mechanisms of the NLRP3 inflammasome, a novel immune-inflammatory marker in cardiovascular diseases","volume":"10","author":"An","year":"2019","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"925923","DOI":"10.3389\/fcvm.2022.925923","article-title":"Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis","volume":"9","author":"Jiang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.4049\/jimmunol.156.7.2558","article-title":"Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells","volume":"156","author":"Haraldsen","year":"1996","journal-title":"J Immun"},{"key":"B64","doi-asserted-by":"publisher","first-page":"117487","DOI":"10.1016\/j.cca.2023.117487","article-title":"ICAM-1 and VCAM-1: gatekeepers in various inflammatory and cardiovascular disorders","volume":"548","author":"Singh","year":"2023","journal-title":"Clin Chim Acta"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1182\/blood.V84.7.2068.2068","article-title":"Leukocyte-endothelial adhesion molecules","volume":"84","author":"Carlos","year":"1994","journal-title":"Blood"},{"key":"B66","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1189\/jlb.0708400","article-title":"Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases","volume":"85","author":"Van Gils","year":"2009","journal-title":"J Leukoc Biol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1196033","DOI":"10.3389\/fimmu.2023.1196033","article-title":"Monocyte-endothelial cell interactions in vascular and tissue remodeling","volume":"14","author":"Medrano-Bosch","year":"2023","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1016\/j.crvasa.2015.08.002","article-title":"Monocyte adhesion to the endothelium is an initial stage of atherosclerosis development","volume":"58","author":"\u010cejkov\u00e1","year":"2016","journal-title":"Cor Vasa"},{"key":"B69","doi-asserted-by":"publisher","first-page":"777822","DOI":"10.3389\/fcvm.2022.777822","article-title":"Lipid-laden macrophages and inflammation in atherosclerosi s and cancer: an integrative view","volume":"9","author":"Lee-Rueckert","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"785220","DOI":"10.3389\/fphar.2021.785220","article-title":"Roles of macrophages in atherogenesis","volume":"12","author":"Farahi","year":"2021","journal-title":"Front Pharmacol"},{"key":"B71","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/B978-0-12-812348-5.00033-7","article-title":"Endothelium in atherosclerosis: plaque formation and its complications","volume-title":"Endothelium and Cardiovascular Diseases","author":"da Luz","year":"2018"},{"key":"B72","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000250095","article-title":"Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis","volume":"47","author":"Orr","year":"2010","journal-title":"J Vasc Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"5694","DOI":"10.3390\/ijms20225694","article-title":"The role of vascular smooth muscle cells in arterial remodeling: focus on calcification-related processes","volume":"20","author":"Jaminon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B74","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1111\/bph.14779","article-title":"The role of smooth muscle cells in plaque stability: therapeutic targeting potential","volume":"176","author":"Harman","year":"2019","journal-title":"Br J Pharmacol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/joim.12296","article-title":"Thrombosis formation on atherosclerotic lesions and plaque rupture","volume":"276","author":"Badimon","year":"2014","journal-title":"J Intern Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/hr.2016.35","article-title":"Hypertension as an autoimmune and inflammatory disease","volume":"39","author":"Solak","year":"2016","journal-title":"Hypertens Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1042\/CS20220797","article-title":"Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation","volume":"138","author":"Toto\u0144-\u017bura\u0144ska","year":"2024","journal-title":"Clin Sci"},{"key":"B78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2021.4928","article-title":"Role of the central renin-angiotensin system in hypertension","volume":"47","author":"Su","year":"2021","journal-title":"Int J Mol Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol Rev"},{"key":"B80","first-page":"621","article-title":"Oxidative stress and hypertension","volume":"93","author":"Harrison","year":"2009","journal-title":"Med Clin"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1089\/ars.2012.4604","article-title":"Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease","volume":"19","author":"Dikalov","year":"2013","journal-title":"Antioxid Redox Signaling"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3390\/antiox9121292","article-title":"Oxidative stress and antioxidant treatments in cardiovascular diseases","volume":"9","author":"Wang","year":"2020","journal-title":"Antioxidants"},{"key":"B83","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.114.03575","article-title":"Endothelial dysfunction and hypertension","volume":"64","author":"Brandes","year":"2014","journal-title":"Hypertension"},{"key":"B84","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1134\/S1990747819030140","article-title":"Markers of endothelial cells in normal and pathological conditions","volume":"14","author":"Goncharov","year":"2020","journal-title":"Biochem (Mosc) Suppl A Membr Cell Biol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"H317","DOI":"10.1152\/ajpheart.00182.2013","article-title":"New paradigms in inflammatory signaling in vascular endothelial cells","volume":"306","author":"Xiao","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B86","first-page":"153","article-title":"Endothelial nitric oxide synthase (eNOS) and the cardiovascular system: in physiology and in disease states","volume":"15","author":"Tran","year":"2022","journal-title":"Am J Biomed Sci Res"},{"key":"B87","first-page":"2245","article-title":"Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase","volume":"19","author":"Yang","year":"2019","journal-title":"Mol Med Rep"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1097\/HJH.0000000000000587","article-title":"Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension","volume":"33","author":"Li","year":"2015","journal-title":"J Hypertens"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1098725","DOI":"10.3389\/fimmu.2022.1098725","article-title":"Role of inflammation, immunity, and oxidative stress in hypertension: new insights and potential therapeutic targets","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.116.07237","article-title":"Activation of human T cells in hypertension: studies of humanized mice and hypertensive humans","volume":"68","author":"Itani","year":"2016","journal-title":"Hypertension"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and interferon-\u03b3 are produced concomitantly by human coronary artery\u2013infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"key":"B92","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1307432","DOI":"10.3389\/fendo.2023.1307432","article-title":"Burden of type 1 and type 2 diabetes and high fasting plasma glucose in Europe, 1990\u20132019: a comprehensive analysis from the global burden of disease study 2019","volume":"14","author":"Liang","year":"2023","journal-title":"Front Endocrinol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2042018820906016","DOI":"10.1177\/2042018820906016","article-title":"Insulin-delivery methods for children and adolescents with type 1 diabetes","volume":"11","author":"Zuberi","year":"2020","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1305839","DOI":"10.3389\/fendo.2023.1305839","article-title":"Changes in body mass index and waist circumference and heart failure in type 2 diabetes mellitus","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Endocrinol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1276836","DOI":"10.3389\/fendo.2023.1276836","article-title":"Assessment of potential risk factors associated with gestational diabetes mellitus: evidence from a Mendelian randomization study","volume":"14","author":"Fu","year":"2023","journal-title":"Front Endocrinol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1422752","DOI":"10.3389\/fendo.2024.1422752","article-title":"Environmental endocrine disruptor-induced mitochondrial dysfunction: a potential mechanism underlying diabetes and its complications","volume":"15","author":"He","year":"2024","journal-title":"Front Endocrinol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1307468","DOI":"10.3389\/fendo.2023.1307468","article-title":"Dissecting causal associations of type 2 diabetes with 111 types of ocular conditions: a Mendelian randomization study","volume":"14","author":"Chen","year":"2023","journal-title":"Front Endocrinol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"e15031","DOI":"10.1111\/dme.15031","article-title":"Bone marrow stromal cell-derived exosomal circular RNA improves diabetic foot ulcer wound healing by activating the nuclear factor erythroid 2-related factor 2 pathway and inhibiting ferroptosis","volume":"40","author":"Chen","year":"2023","journal-title":"Diabet Med"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1085092","DOI":"10.3389\/fendo.2022.1085092","article-title":"Review of the correlation between Chinese medicine and intestinal microbiota on the efficacy of diabetes mellitus","volume":"13","author":"Su","year":"2022","journal-title":"Front Endocrinol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"803924","DOI":"10.3389\/fnut.2022.803924","article-title":"Comparing SARC-CalF with SARC-F for screening sarcopenia in adults with type 2 diabetes Mellitus","volume":"9","author":"Xu","year":"2022","journal-title":"Front Nutr"},{"key":"B102","doi-asserted-by":"publisher","first-page":"981100","DOI":"10.3389\/fendo.2022.981100","article-title":"Identification of potential biomarkers and pathways associated with carotid atherosclerotic plaques in type 2 diabetes mellitus: a transcriptomics study","volume":"13","author":"Yu","year":"2022","journal-title":"Front Endocrinol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"106789","DOI":"10.1016\/j.ijsu.2022.106789","article-title":"The impact of diabetes on postoperative outcomes following spine surgery: a meta-analysis of 40 cohort studies with 2.9 million participants","volume":"104","author":"Luo","year":"2022","journal-title":"Int J Surg"},{"key":"B104","first-page":"4499","article-title":"Meta-analysis of the association between aldose reductase gene (CA)n microsatellite variants and risk of diabetic retinopathy","volume":"18","author":"Mi","year":"2019","journal-title":"Exp Ther Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e40412","DOI":"10.1097\/MD.0000000000040412","article-title":"Exploring the causal relationships between type 2 diabetes and neurological disorders using a Mendelian randomization strategy","volume":"103","author":"Wei","year":"2024","journal-title":"Medicine"},{"key":"B106","doi-asserted-by":"publisher","first-page":"695792","DOI":"10.3389\/fmed.2021.695792","article-title":"The diabetic cardiomyopathy: the contributing pathophysiological mechanisms","volume":"8","author":"Salvatore","year":"2021","journal-title":"Front Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3389\/fphys.2017.00519","article-title":"NLRP3 Inflammasome as a molecular marker in diabetic cardiomyopathy","volume":"8","author":"Luo","year":"2017","journal-title":"Front Physiol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1002710","DOI":"10.3389\/fmolb.2022.1002710","article-title":"Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications","volume":"9","author":"Mengstie","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B109","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/dmrr.2560","article-title":"AGEs and chronic subclinical inflammation in diabetes: disorders of immune system","volume":"31","author":"Hu","year":"2015","journal-title":"Diabetes Metab Res Rev"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.26599\/FSHW.2022.9250094","article-title":"Effects of Maillard reaction and its product AGEs on aging and age-related diseases","volume":"13","author":"Peng","year":"2024","journal-title":"Food Sci Hum Wellness"},{"key":"B111","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10522-019-09808-3","article-title":"The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging","volume":"20","author":"Teissier","year":"2019","journal-title":"Biogerontology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"931473","DOI":"10.3389\/fimmu.2022.931473","article-title":"Pathophysiology of RAGE in inflammatory diseases","volume":"13","author":"Dong","year":"2022","journal-title":"Front Immunol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1155175","DOI":"10.3389\/fnmol.2023.1155175","article-title":"AGE-RAGE axis culminates into multiple pathogenic processes: a central road to neurodegeneration","volume":"16","author":"Bhattacharya","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s12035-017-0419-4","article-title":"RAGE-TLR crosstalk sustains chronic inflammation in neurodegeneration","volume":"55","author":"G\u0105siorowski","year":"2018","journal-title":"Mol Neurobiol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s11010-020-03928-y","article-title":"AGE-RAGE synergy influences programmed cell death signaling to promote cancer","volume":"476","author":"Waghela","year":"2021","journal-title":"Mol Cell Biochem"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-016-0303-y","article-title":"Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?","volume":"23","author":"Rehman","year":"2016","journal-title":"J Biomed Sci"},{"key":"B117","doi-asserted-by":"publisher","first-page":"R673","DOI":"10.1152\/ajpregu.00561.2007","article-title":"Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species","volume":"294","author":"Wei","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1530\/JOE-16-0598","article-title":"Skeletal muscle insulin resistance: role of mitochondria and other ROS sources","volume":"233","author":"Di Meo","year":"2017","journal-title":"J Endocrinol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3390\/ijms25021082","article-title":"The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease","volume":"25","author":"Zhang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B120","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1016\/j.ijcard.2013.07.150","article-title":"An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy","volume":"168","author":"Palomer","year":"2013","journal-title":"Int J Cardiol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00109-022-02269-1","article-title":"Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy","volume":"100","author":"Chen","year":"2022","journal-title":"J Mol Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"842723","DOI":"10.3389\/fphar.2022.842723","article-title":"Baicalein ameliorates myocardial ischemia through reduction of oxidative stress, inflammation and apoptosis via TLR4\/MyD88\/MAPKS\/NF-\u03baB pathway and regulation of Ca2\u2009+\u2009homeostasis by L-type Ca2\u2009+\u2009channels","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s10020-023-00715-5","article-title":"AGEs promote atherosclerosis by increasing LDL transcytosis across endothelial cells via RAGE\/NF-\u03baB\/caveolin-1 pathway","volume":"29","author":"Shu","year":"2023","journal-title":"Mol Med"},{"key":"B124","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.3390\/biomedicines10092274","article-title":"Coronary microvascular dysfunction in diabetes mellitus: pathogenetic mechanisms and potential therapeutic options","volume":"10","author":"Salvatore","year":"2022","journal-title":"Biomedicines"},{"key":"B125","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13098-024-01396-8","article-title":"INFLA Score: a novel inflammatory marker for assessing cardiometabolic disease risk in obese individuals","volume":"16","author":"Liu","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"B126","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/antiox13010087","article-title":"The intersection of genetic factors, aberrant nutrient metabolism and oxidative stress in the progression of cardiometabolic disease","volume":"13","author":"Butcko","year":"2024","journal-title":"Antioxidants"},{"key":"B127","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/metabo13060760","article-title":"Dietary patterns, gut microbiota remodeling, and cardiometabolic disease","volume":"13","author":"Guiducci","year":"2023","journal-title":"Metabolites"},{"key":"B128","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.3390\/ijms24076292","article-title":"Benefits of biotics for cardiovascular diseases","volume":"24","author":"Hijov\u00e1","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B129","doi-asserted-by":"crossref","first-page":"106983","DOI":"10.1016\/j.phrs.2023.106983","article-title":"Danger-associated metabolites trigger metaflammation: a crowbar in cardiometabolic diseases","volume":"198","author":"Wang","year":"2023","journal-title":"Pharmacol Res"},{"key":"B130","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1038\/s41467-024-49921-7","article-title":"Abdominal aortic aneurysm and cardiometabolic traits share strong genetic susceptibility to lipid metabolism and inflammation","volume":"15","author":"Zheng","year":"2024","journal-title":"Nat Commun"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1136\/heartjnl-2022-321959","article-title":"Inflammatory proteomics profiling for prediction of incident atrial fibrillation","volume":"109","author":"B\u00f6rschel","year":"2023","journal-title":"Heart"},{"key":"B132","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.semcdb.2022.09.008","article-title":"Epigenetic regulation of inflammation: the metabolomics connection","volume":"154","author":"Rath","year":"2024","journal-title":"Semin Cell Dev Biol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1529903\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T01:11:33Z","timestamp":1736817093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1529903\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":132,"alternative-id":["10.3389\/fcvm.2024.1529903"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1529903","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"article-number":"1529903"}}